Y-mAbs Therapeutics, Inc.

YMAB · NASDAQ
Analyze with AI
6/30/2025
3/31/2025
12/31/2024
9/30/2024
Assets
Cash & Equivalents$62,293$60,310$67,234$68,122
Short-Term Investments$0$0$0$0
Receivables$15,740$17,740$19,688$19,916
Inventory$9,719$7,995$7,214$9,557
Other Curr. Assets$4,035$4,403$4,373$1,462
Total Curr. Assets$91,787$90,448$98,509$99,057
Property Plant & Equip (Net)$3,378$762$859$1,128
Goodwill$0$0$0$0
Intangibles$2,177$2,213$2,276$2,366
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$19,869$19,190$18,260$18,366
Total NC Assets$25,424$22,165$21,395$21,860
Other Assets$0$0$0$0
Total Assets$117,211$112,613$119,904$120,917
Liabilities
Payables$7,571$4,627$6,662$7,878
Short-Term Debt$486$0$0$0
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$11,301$3,288$16,406$16,638
Total Curr. Liab.$22,945$18,957$23,698$25,292
LT Debt$2,638$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$4,135$4,051$4,012$2,897
Total NC Liab.$6,773$4,199$4,202$3,196
Other Liabilities$0$0$0$0
Cap. Leases$3,124$603$820$1,075
Total Liabilities$29,718$23,156$27,900$28,488
Equity
Pref Stock$0$0$0$0
Common Stock$5$5$4$4
Retained Earnings-$495,571-$492,332-$487,136-$480,346
AOCI-$612$1,401$2,264-$36
Other Equity$583,671$0$0$0
Total Equity$87,493$89,457$92,004$92,429
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$117,211$112,613$119,904$120,917
Net Debt-$59,169-$60,310-$67,234-$68,122
Y-mAbs Therapeutics, Inc. (YMAB) Financial Statements & Key Stats | AlphaPilot